This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Song, C. S. Articles by Roy, A. K. Search for Related Content PubMed PubMed Citation Articles by Song, C. S. Articles by Roy, A. K.

Negative Regulation of the Androgen Receptor Gene Promoter by NFI and an Adjacently Located Multiprotein-Binding Site

Department of Cellular and Structural Biology (C.S.S., M.H.J., P.C.S., B.C., A.K.R.) The University of Texas Health Science Center at San Antonio San Antonio, Texas 78284
Audie L. Murphy Memorial VA Hospital (B.C.) San Antonio, Texas 78284

The upstream promoter of the rat androgen receptor (AR) gene contains a strong negative regulatory region located at the -388 to -340 nucleotide position. The distal part (-388/-373) of this regulatory region binds NFI, a ubiquitous transcription factor, while the proximal portion (-372/-340) contains an overlapping binding site for two nuclear proteins. This composite regulatory region (-388/-340) was initially defined by deoxyribonuclease I footprinting as the continuous stretch of a nuclease-protected site. NFI specificity of the distal portion (-388/-373) of the footprint was established through cross-competition in electrophoretic mobility shift assay (EMSA) using the well characterized NFI element of the adenovirus major late promoter and by immunoreactivity to the NFI antibody. EMSA with oligonucleotide duplexes corresponding to the proximal domain (-372/-340) indicated multiple retarded bands with at least two major DNA-protein complexes. Further analysis with truncated oligonucleotide duplexes showed that these two major proteins bind to this domain in an overlapping manner. Within this overlapping area, the position spanning -359 to -347 is essential for the formation of either of these two complexes. Substitution of four G with T residues in the overlapping area totally abolished all protein binding at the downstream -372/-340 site. Point mutations that abolish specific binding at either the NFI or immediately downstream multiprotein-binding site caused about a 10-fold increase in AR promoter activity in transfected HepG2 cells. Double mutation involving both the NFI and proximal overlapping protein-binding sites failed to cause any additional increase in promoter function. From these results we conclude that the AR promoter contains a composite negative regulatory region at -388/-340, and the repressor function may involve a coordinate interaction between NFI and at least two other nuclear factors.

This article has been cited by other articles:

				J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11897 - 11906. [Abstract] [Full Text] [PDF]

				L. Yang, S. Xie, Md. S. Jamaluddin, S. Altuwaijri, J. Ni, E. Kim, Y.-T. Chen, Y.-C. Hu, L. Wang, K.-H. Chuang, et al. Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells J. Biol. Chem., September 30, 2005; 280(39): 33558 - 33565. [Abstract] [Full Text] [PDF]

				H. Xu, J. K. Uno, M. Inouye, J. F. Collins, and F. K. Ghishan NF1 transcriptional factor(s) is required for basal promoter activation of the human intestinal NaPi-IIb cotransporter gene Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G175 - G181. [Abstract] [Full Text] [PDF]

				L. Zhang, M. Charron, W. W. Wright, B. Chatterjee, C. S. Song, A. K. Roy, and T. R. Brown Nuclear Factor-{kappa}B Activates Transcription of the Androgen Receptor Gene in Sertoli Cells Isolated from Testes of Adult Rats Endocrinology, February 1, 2004; 145(2): 781 - 789. [Abstract] [Full Text] [PDF]

				D. K. Lee and C. Chang Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054. [Abstract] [Full Text] [PDF]

				E. D. Martinez and M. Danielsen Loss of Androgen Receptor Transcriptional Activity at the G1/S Transition J. Biol. Chem., August 9, 2002; 277(33): 29719 - 29729. [Abstract] [Full Text] [PDF]

				Long. G. Wang, L. Ossowski, and A. C. Ferrari Overexpressed Androgen Receptor Linked to p21WAF1 Silencing May Be Responsible for Androgen Independence and Resistance to Apoptosis of a Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(20): 7544 - 7551. [Abstract] [Full Text] [PDF]

				P. Jethanandani and E. Goldberg ldhc Expression in Non-germ Cell Nuclei Is Repressed by NF-I Binding J. Biol. Chem., September 14, 2001; 276(38): 35414 - 35421. [Abstract] [Full Text] [PDF]